645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Hyo Han; Elizabeth Evans; Terrence Fisher; Hatem Soliman; Hung Khong; Aixa Soyano; Ricardo Costa; Loretta Loftus; Kimberley Lee; Avan Armaghani; Hien Liu; Frederick Locke; Alexandria Shrewsbury; Jessica Malka; Lavakumar Karyampudi; Maurice Zauderer; Brian Czerniecki

doi:10.1136/jitc-2022-SITC2022.0645

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Free

Authors

Hyo Han Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Elizabeth Evans Vaccinex, Inc., Rochester, NY, USA PubMed articles Google scholar articles
Terrence Fisher Vaccinex, Inc., Rochester, NY, USA PubMed articles Google scholar articles
Hatem Soliman Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Hung Khong Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Aixa Soyano Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Ricardo Costa Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Loretta Loftus Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Kimberley Lee Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Avan Armaghani Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Hien Liu Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Frederick Locke Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Alexandria Shrewsbury Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Jessica Malka Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Lavakumar Karyampudi Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Maurice Zauderer Vaccinex, Inc., Rochester, NY, USA PubMed articles Google scholar articles
Brian Czerniecki Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles

Citation

Han H, Evans E, Fisher T, et al

645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0645

Publication history

First published November 7, 2022.

Online issue publication

November 07, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password